CTMedic writes: ————————-
Post# of 148292
————————-
“ Carolyn Johnson is a science reporter. She previously covered the business of health, the pharmaceutical industry and the affordability of health care to consumers. Before coming to the Post, she covered science at the Boston Globe.”
We are unlikely to find someone more qualified to appreciate and amplify the Cytodyn story.
Read More: https://investorshangout.com/post/view?id=586...z6V7ZJXi9P
————————
So you look at Carolyn’s credentials and pedigree and you get some reassurance that she’s good at what she does. Why are investors judged when they do the same with Cytodyn? Why are BP and bankers criticized for not playing along with NP?
Shows you’re not impartial.